FDA Removes Black Box Warning on Menopause Hormone Therapy

The FDA has removed the 'black box' warning on hormone replacement therapy for menopause, citing new research that shows the treatments are safer than previously thought, which may increase their use among women and doctors. The agency will still warn about endometrial cancer risk and has approved two new menopause-related drugs. This change follows a reevaluation of past studies linking hormone therapy to serious health risks, and reflects a broader shift in conversations about women's health during midlife.